Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Immunogenicity and Safety Evaluation of a Newly Manufactured Recombinant Baculovirus-Expressed Quadrivalent Influenza Vaccine in Adults 18 Years Old and Above: An Open-Label, Phase Iii Extension Study
Ramin Rahimnia
Ramin Rahimnia

Assistant Professor of Medical Nanotechnology

Department Medical Nanotechnology

School of Advanced Technologies in Medicine

Tehran University of Medical Sciences

All Documents